Back
Anadolu Efes Biracilik ve Malt Sanayii A.S. 10K Form
Sell
43
AEBZY
Anadolu Efes Biracilik ve Malt Sanayii A.S.
Last Price:
$0.31
Seasonality Move:
2.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AEBZY News And Ratings
See the #1 stock for the next 7 days that we like better than AEBZY
AEBZY Financial Statistics
Sales & Book Value
| Annual Sales: | $7B |
|---|---|
| Cash Flow: | $214.5M |
| Price / Cash Flow: | 6.74 |
| Annual Sales: | $0.41 |
| Price / Book: | 0.75 |
Profitability
| EPS (TTM): | 0.05310 |
|---|---|
| Net Income (TTM): | $497.7M |
| Gross Margin: | $2.6B |
| Return on Equity: | 10.12% |
| Return on Assets: | 5.03% |
Anadolu Efes Biracilik ve Malt Sanayii A.S. Earnings Forecast
Key Anadolu Efes Biracilik ve Malt Sanayii A.S. Financial Ratios
-
The Gross Profit Margin over the past 33 years for AEBZY is 36.98%.
-
The Selling, General & Administrative Expenses for AEBZY have been equal to 27.78% of Gross Profit Margin.
-
The Research & Development expenses have been 0.12% of Revenue.
-
The Interest Expense is 73.11% of Operating Income.
-
The Net Earning history of AEBZY is 10.09% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 11 years.
Anadolu Efes Biracilik ve Malt Sanayii A.S. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Beverages |
| Sector: | Consumer Staples |
| Current Symbol: | AEBZY |
| Website: | anadoluefes.com |
Debt
| Debt-to-Equity Ratio: | 0.98 |
|---|---|
| Current Ratio: | 1.05 |
| Quick Ratio: | 0.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.59 |
|---|---|
| Forward P/E Ratio: | 0 |
AEBZY Technical Analysis vs Fundamental Analysis
Sell
43
Anadolu Efes Biracilik ve Malt Sanayii A.S. (AEBZY)
is a Sell
Is Anadolu Efes Biracilik ve Malt Sanayii A.S. a Buy or a Sell?
-
Anadolu Efes Biracilik ve Malt Sanayii A.S. stock is rated a SellThe current Anadolu Efes Biracilik ve Malt Sanayii A.S. [AEBZY] share price is $0.31. The Score for AEBZY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.